SCHEMBL6287589

SCHEMBL6287589

Fc1ccc(Cc2cccc(Cl)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
GRIN2B Q13224 2/20 0.53
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PNMT P11086 2/20 0.50
TAAR1 Q96RJ0 2/20 0.47
LTA4H P09960 1/20 0.47
IDO1 P14902 2/20 0.46
AGXT P21549 2/20 0.46
ALDH1A1 P00352 2/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
KMT2A Q03164 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14931455 0.86 GRIN2B (0.53) CYP3A4CYP1A2CYP2D6CYP2C19GRIN2B
SCHEMBL2093970 0.85 PNMT (0.56) CYP3A4GRIN2BLMNAPNMTTAAR1
SCHEMBL16504800 0.85 LOXL2 (0.50) CYP3A4LMNATAAR1IDO1AGXT
SCHEMBL3300276 0.85 PNMT (0.65) CYP3A4PNMTTAAR1IDO1AGXT
SCHEMBL3301781 0.83 PNMT (0.58) CYP3A4GRIN2BPNMTTAAR1IDO1
SCHEMBL5507487 0.82 PNMT (0.77) CYP3A4CYP1A2CYP2D6CYP2C19GRIN2B
SCHEMBL8993096 0.82 PNMT (0.52) CYP3A4PNMTTAAR1LTA4HIDO1
SCHEMBL7929350 0.81 TAAR1 (0.52) CYP3A4SMN1; SMN2TAAR1IDO1AGXT
Ammonia Solution, Strong SCHEMBL18010559 0.81 PNMT (0.56) CYP3A4GRIN2BPNMTTAAR1IDO1
SCHEMBL21384185 0.80 TAAR1 (0.57) CYP3A4PNMTTAAR1LTA4HIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104045513-A 4-substituted-1-chloro-2-(4-fluorobenzyl)benzene, its preparation method and application as intermediate in preparation of anti-type II diabetes drugs IKON PHARMACEUTICALS LLC 2014-09-17 CN disclosed
US-6951918-B2 Peptidic procollagen C-proteinase inhibitors SYNTEX (U.S.A.) LLC (US) 2005-10-04 US disclosed